These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1042 related articles for article (PubMed ID: 15231732)
1. A central role for inflammation in the pathogenesis of diabetic retinopathy. Joussen AM; Poulaki V; Le ML; Koizumi K; Esser C; Janicki H; Schraermeyer U; Kociok N; Fauser S; Kirchhof B; Kern TS; Adamis AP FASEB J; 2004 Sep; 18(12):1450-2. PubMed ID: 15231732 [TBL] [Abstract][Full Text] [Related]
2. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Barouch FC; Miyamoto K; Allport JR; Fujita K; Bursell SE; Aiello LP; Luscinskas FW; Adamis AP Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1153-8. PubMed ID: 10752954 [TBL] [Abstract][Full Text] [Related]
3. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy. Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613 [TBL] [Abstract][Full Text] [Related]
4. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Miyamoto K; Khosrof S; Bursell SE; Rohan R; Murata T; Clermont AC; Aiello LP; Ogura Y; Adamis AP Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10836-41. PubMed ID: 10485912 [TBL] [Abstract][Full Text] [Related]
5. Effects of peroxisome proliferator-activated receptor gamma and its ligand on blood-retinal barrier in a streptozotocin-induced diabetic model. Muranaka K; Yanagi Y; Tamaki Y; Usui T; Kubota N; Iriyama A; Terauchi Y; Kadowaki T; Araie M Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4547-52. PubMed ID: 17003451 [TBL] [Abstract][Full Text] [Related]
6. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Joussen AM; Poulaki V; Qin W; Kirchhof B; Mitsiades N; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP Am J Pathol; 2002 Feb; 160(2):501-9. PubMed ID: 11839570 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488 [TBL] [Abstract][Full Text] [Related]
8. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Joussen AM; Murata T; Tsujikawa A; Kirchhof B; Bursell SE; Adamis AP Am J Pathol; 2001 Jan; 158(1):147-52. PubMed ID: 11141487 [TBL] [Abstract][Full Text] [Related]
9. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway. Nagai N; Izumi-Nagai K; Oike Y; Koto T; Satofuka S; Ozawa Y; Yamashiro K; Inoue M; Tsubota K; Umezawa K; Ishida S Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4342-50. PubMed ID: 17724226 [TBL] [Abstract][Full Text] [Related]
10. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481 [TBL] [Abstract][Full Text] [Related]
11. VEGF increases retinal vascular ICAM-1 expression in vivo. Lu M; Perez VL; Ma N; Miyamoto K; Peng HB; Liao JK; Adamis AP Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1808-12. PubMed ID: 10393052 [TBL] [Abstract][Full Text] [Related]
12. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina. Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055 [TBL] [Abstract][Full Text] [Related]
14. Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy. Zheng L; Howell SJ; Hatala DA; Huang K; Kern TS Diabetes; 2007 Feb; 56(2):337-45. PubMed ID: 17259377 [TBL] [Abstract][Full Text] [Related]
15. Increased basement membrane thickness, pericyte ghosts, and loss of retinal thickness and cells in dopamine beta hydroxylase knockout mice. Steinle JJ; Kern TS; Thomas SA; McFadyen-Ketchum LS; Smith CP Exp Eye Res; 2009 Jun; 88(6):1014-9. PubMed ID: 19176214 [TBL] [Abstract][Full Text] [Related]
16. Phosphomannopentaose sulfate (PI-88) inhibits retinal leukostasis in diabetic rat. Ma P; Luo Y; Zhu X; Ma H; Hu J; Tang S Biochem Biophys Res Commun; 2009 Mar; 380(2):402-6. PubMed ID: 19250642 [TBL] [Abstract][Full Text] [Related]
17. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia. Kern TS; Tang J; Mizutani M; Kowluru RA; Nagaraj RH; Romeo G; Podesta F; Lorenzi M Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301 [TBL] [Abstract][Full Text] [Related]
18. Captopril inhibits capillary degeneration in the early stages of diabetic retinopathy. Zhang JZ; Xi X; Gao L; Kern TS Curr Eye Res; 2007 Oct; 32(10):883-9. PubMed ID: 17963108 [TBL] [Abstract][Full Text] [Related]
19. T cell-associated CD18 but not CD62L, ICAM-1, or PSGL-1 is required for the induction of chronic colitis. Ostanin DV; Furr KL; Pavlick KP; Gray L; Kevil CG; Shukla D; D'Souza D; Hoffman JM; Grisham MB Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1706-14. PubMed ID: 17332469 [TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor up-regulates the expression of intracellular adhesion molecule-1 in retinal endothelial cells via reactive oxygen species, but not nitric oxide. Zhang XL; Wen L; Chen YJ; Zhu Y Chin Med J (Engl); 2009 Feb; 122(3):338-43. PubMed ID: 19236815 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]